← Back to Search

Antiplatelet Agent

Low-Dose Aspirin for Preeclampsia (TAP Trial)

Phase 4
Recruiting
Led By Alisse K Hauspurg, MD
Research Sponsored by Alisse Hauspurg
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Must not have
Pre-pregnancy hypertension
Aspirin use during pregnancy or planned aspirin use in the postpartum period
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 to 6 months postpartum
Awards & highlights

Summary

"This trial aims to test if taking low-dose aspirin after preeclampsia in the immediate postpartum period can help improve blood vessel recovery. They will enroll up to 60 participants

Who is the study for?
This trial is for postpartum individuals over 18 who were diagnosed with preeclampsia. It's not open to those with pre-pregnancy hypertension or diabetes, allergies to aspirin, multiple gestations, fetal anomalies, or anyone who used aspirin during pregnancy.
What is being tested?
The TAP Trial is testing if low-dose aspirin can help improve blood vessel function and lower blood pressure after preeclampsia. Participants will be randomly given either aspirin or a placebo and monitored through visits involving BP checks and other tests.
What are the potential side effects?
Low-dose aspirin may cause side effects like gastrointestinal issues (like stomach pain), bleeding problems, allergic reactions in some people, but many take it without serious issues.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I had high blood pressure before getting pregnant.
Select...
I am taking or plan to take aspirin during or after my pregnancy.
Select...
I am allergic to or cannot take low-dose aspirin.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 to 6 months postpartum
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 to 6 months postpartum for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percent of participants eligible, enrolled and retained (feasibility)
Secondary study objectives
Anti-hypertensive medication use
Change in diastolic blood pressure
Change in mean arterial pressure
+22 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention GroupExperimental Treatment1 Intervention
Low-dose \[81 mg\] aspirin pill daily for 6 months will be given to subjects
Group II: Placebo GroupPlacebo Group1 Intervention
Similar appearing placebo pill daily for 6 months will be given to subjects.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low-dose aspirin
2019
Completed Phase 2
~240

Find a Location

Who is running the clinical trial?

Alisse HauspurgLead Sponsor
2 Previous Clinical Trials
170 Total Patients Enrolled
2 Trials studying Hypertension
170 Patients Enrolled for Hypertension
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,889 Previous Clinical Trials
47,834,147 Total Patients Enrolled
475 Trials studying Hypertension
2,701,488 Patients Enrolled for Hypertension
Alisse K Hauspurg, MDPrincipal InvestigatorUPMC Magee Women's Hospital
1 Previous Clinical Trials
60 Total Patients Enrolled
1 Trials studying Hypertension
60 Patients Enrolled for Hypertension
~40 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top